Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for immunoassays in disease diagnosis
3.2.1.2 Growing investments in biomedical research
3.2.1.3 Growing demand for drug development and drug quality control
3.2.1.4 Advances in enzyme engineering and production
3.2.2 Industry pitfalls & challenges
3.2.2.1 Risk related to consistent availability of raw materials
3.2.2.2 Concerns related to storage and low shelf life
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Substrate, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Chromogenic
5.2.1 TMB (3,3’,5,5’-tetramethylbenzidine)
5.2.2 ABTS (2,2'-azinobis [3- ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
5.2.3 OPD (ophenylenediamine dihydrochloride)
5.3 Chemiluminescent
5.4 Fluorogenic
5.5 Luminescent
5.6 Electrochemical
Chapter 6 Market Estimates and Forecast, By Grade, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Grade I
6.3 Grade II
6.4 Grade III
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Immunoassays
7.2.1 ELISA
7.2.2 BLOT test
7.2.3 Other immunoassays
7.3 Biosensors
Chapter 8 Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Diagnostic centers
8.3 Biopharmaceutical companies
8.4 Academic and research centers
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abcam Limited
10.2 Abnova Corporation
10.3 BBI Solutions
10.4 Bio-rad Laboratories, Inc.
10.5 Creative Enzymes
10.6 Enzo Life Sciences, Inc.
10.7 F. Hoffman-La Roche Ltd.
10.8 Faizyme Laboratories (Pty) Ltd
10.9 GenScript
10.10 Merck KGaA
10.11 Oriental Yeast Co., Ltd.
10.12 Promega Corporation
10.13 Santa Cruz Biotechnology, Inc.
10.14 Takara Bio Inc.
10.15 Thermo Fisher Scientific Inc.
